Cargando…
Database of adverse events associated with drugs and drug combinations
Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934730/ https://www.ncbi.nlm.nih.gov/pubmed/31882773 http://dx.doi.org/10.1038/s41598-019-56525-5 |
_version_ | 1783483451453734912 |
---|---|
author | Poleksic, Aleksandar Xie, Lei |
author_facet | Poleksic, Aleksandar Xie, Lei |
author_sort | Poleksic, Aleksandar |
collection | PubMed |
description | Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical trials typically focus on individual drugs rather than drug combinations and animal models are unreliable. An added difficulty is the combinatorial explosion in the number of possible combinations that can be made using the increasingly large set of FDA approved chemicals. We present a statistical and computational technique for identifying AEs caused by two-drug combinations. Taking advantage of the large and increasing data deposited in FDA’s postmarketing reports, we demonstrate that the task of predicting AEs for 2-drug combinations is amenable to the Likelihood Ratio Test (LRT). Our pAERS database constructed with LRT contains almost 77 thousand associations between pairs of drugs and corresponding AEs caused solely by drug-drug interactions (DDIs). The DDIs stored in pAERS complement the existing data sets. Due to our stringent statistical test, we expect many of the associations in pAERS to be unrecorded or poorly documented in the literature. |
format | Online Article Text |
id | pubmed-6934730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69347302019-12-30 Database of adverse events associated with drugs and drug combinations Poleksic, Aleksandar Xie, Lei Sci Rep Article Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical trials typically focus on individual drugs rather than drug combinations and animal models are unreliable. An added difficulty is the combinatorial explosion in the number of possible combinations that can be made using the increasingly large set of FDA approved chemicals. We present a statistical and computational technique for identifying AEs caused by two-drug combinations. Taking advantage of the large and increasing data deposited in FDA’s postmarketing reports, we demonstrate that the task of predicting AEs for 2-drug combinations is amenable to the Likelihood Ratio Test (LRT). Our pAERS database constructed with LRT contains almost 77 thousand associations between pairs of drugs and corresponding AEs caused solely by drug-drug interactions (DDIs). The DDIs stored in pAERS complement the existing data sets. Due to our stringent statistical test, we expect many of the associations in pAERS to be unrecorded or poorly documented in the literature. Nature Publishing Group UK 2019-12-27 /pmc/articles/PMC6934730/ /pubmed/31882773 http://dx.doi.org/10.1038/s41598-019-56525-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Poleksic, Aleksandar Xie, Lei Database of adverse events associated with drugs and drug combinations |
title | Database of adverse events associated with drugs and drug combinations |
title_full | Database of adverse events associated with drugs and drug combinations |
title_fullStr | Database of adverse events associated with drugs and drug combinations |
title_full_unstemmed | Database of adverse events associated with drugs and drug combinations |
title_short | Database of adverse events associated with drugs and drug combinations |
title_sort | database of adverse events associated with drugs and drug combinations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934730/ https://www.ncbi.nlm.nih.gov/pubmed/31882773 http://dx.doi.org/10.1038/s41598-019-56525-5 |
work_keys_str_mv | AT poleksicaleksandar databaseofadverseeventsassociatedwithdrugsanddrugcombinations AT xielei databaseofadverseeventsassociatedwithdrugsanddrugcombinations |